Antibodies to aquaporins are frequent in patients with primary Sjögren's syndrome.
- Published in:
- Rheumatology, 2017, v. 56, n. 12, p. 2114, doi. 10.1093/rheumatology/kex328
- By:
- Publication type:
- Article
Works by Andonopoulos, Andrew P.
Results: 17
1
2
Peripheral blood mononuclear cells from patients with rheumatoid arthritis suppress erythropoiesis in vitro via the production of tumor necrosis factor alpha.
- Published in:
- European Journal of Haematology, 1994, v. 53, n. 1, p. 26, doi. 10.1111/j.1600-0609.1994.tb00175.x
- By:
- Publication type:
- Article
3
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1017-y
- By:
- Publication type:
- Article
4
Brucella arthritis.
- Published in:
- 1986
- By:
- Publication type:
- journal article
5
Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence.
- Published in:
- International Journal of Rheumatology, 2011, v. 2011, p. 1, doi. 10.1155/2011/214013
- By:
- Publication type:
- Article
7
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
- Published in:
- Arthritis Research & Therapy, 2012, v. 14, n. 3, p. 1, doi. 10.1186/ar3879
- By:
- Publication type:
- Article
8
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo.
- Published in:
- 2011
- By:
- Publication type:
- Letter
9
Antiovarian antibodies in primary Sjogren’s syndrome.
- Published in:
- Rheumatology International, 2007, v. 27, n. 12, p. 1149, doi. 10.1007/s00296-007-0364-z
- By:
- Publication type:
- Article
10
Arthritis accompanying ileal pouchitis or undifferentiated HLA B27-related spondyloarthropathy?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
11
Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing Spondylitis.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 3, p. 630, doi. 10.1002/jbmr.2724
- By:
- Publication type:
- Article
12
Bilateral blepharospasm as the presenting symptom of Sjögren's syndrome with evidence of central nervous system involvement.
- Published in:
- Acta Neuropsychiatrica, 2010, v. 22, n. 5, p. 263, doi. 10.1111/j.1601-5215.2010.00485.x
- By:
- Publication type:
- Article
13
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.
- Published in:
- Rheumatology, 2010, v. 49, n. 2, p. 271, doi. 10.1093/rheumatology/kep093
- By:
- Publication type:
- Article
14
ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative study.
- Published in:
- Rheumatology International, 2022, v. 42, n. 6, p. 949, doi. 10.1007/s00296-022-05128-x
- By:
- Publication type:
- Article
15
Adrenocorticotropic hormone: an effective "natural" biologic therapy for acute gout?
- Published in:
- Rheumatology International, 2020, v. 40, n. 12, p. 1941, doi. 10.1007/s00296-020-04659-5
- By:
- Publication type:
- Article
16
B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis.
- Published in:
- Rheumatology International, 2019, v. 39, n. 11, p. 1889, doi. 10.1007/s00296-019-04350-4
- By:
- Publication type:
- Article
17
Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
- Published in:
- Annals of Hematology, 2004, v. 83, n. 11, p. 704, doi. 10.1007/s00277-004-0910-7
- By:
- Publication type:
- Article